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ABSTRACT 
Kawasaki Disease (KD) is an acute, self
small arteries, especially the coronary arteries. The incidence of KD is currently on th
with about 15 to 25 percent of children without systemic treatment, eventually developing 
coronary artery damage, Becoming the most common cause of child
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in the developed countries. At present, stem cell therapy for Kawasaki Disease in mice 
model has made important progress. This article reviews stem cell treatment of coronary 
artery lesion of Kawasaki Disease. 
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INTRODUCTION 
Kawasaki disease (Kawasaki diseases, KD) is a autoimmune disease, also known as lymph 
node syndrome, skin and mucosa in 1967 by a pediatrician Kawasaki rich covered in Japan 
for the first time, develops in children under the age of five, the main is a kind of small 
artery inflammatory lesions in the body, the main pathological changes of acute febrile 
disease and systemic vasculitis [1], more invasion of the heart coronary artery and cause 
serious complications. Coronary Artery Injury (CAL) is a serious complication of Kawasaki 
disease, which has the risk of myocardial infarction and sudden death, and has become the 
primary pathogenic factor of acquired heart disease in children in developed countries. Up 
to 15-20% of patients with Kawasaki disease do not respond to high-dose intravenous 
immunoglobulin therapy, and these patients have a significantly increased incidence of 
coronary aneurysms [2]. So far, scholars on the pathogenesis and pathogenesis of Kawasaki 
disease is not very clear, but through nearly half a century of research support genetic 
factors play a key role in its occurrence and development, and emerged two university 
theories: infection theory and immunity theory. Kawasaki disease is a self-limited disease 
that causes inflammatory changes in blood vessels. It occurs most frequently in East Asian 
populations and occurs most frequently in winter and spring. The clinical manifestations of 
Kawasaki disease overlap with other infectious diseases [3], its clinical biochemical 
indicators, such as increased white blood cell/CRP and rapid erythrocyte sedimentation rate, 
are enough to prove that the underlying lesions are caused by inflammatory cells. During 
the acute onset of Kawasaki disease, a large number of inflammatory cytokines are 
released. After the activation of immune cells, the activated immune cells can release a 
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large number of inflammatory cytokines [4], is a vicious cycle, the formation of waterfall 
reaction, so that the body loses the control of the inflammatory response, resulting in 
endothelial damage. Secondly, a large amount of tumor necrosis factor (TNF) is produced to 
damage vascular endothelial cells, resulting in increased endothelial permeability, and then 
the vascular endothelial cells release chemokines, resulting in the aggregation of immune 
cells to the surface of the damaged vessels. The number of endothelial progenitor cells 
(EPCs) is reduced by tumor cells, thereby reducing the repair of damaged endothelial cells 
and leading to coronary artery damage. Thirdly, during the acute period of Kawasaki's 
disease, the body releases a large amount of interleukin, which enables cells to detect the 
toxic effect, inhibit the expression of P53 gene, reduce the apoptosis of lymphocytes, 
continuously produce more inflammatory factors and adhesion molecules, and mediate the 
damage of vascular endothelial cells [5]. Abnormal activation of T cells is the initial link and 
key step of immune system activation in Kawasaki disease, which leads to vascular immune 
injury [6]. A large number of T cells make the body in a state of immune activation. 
Activated T cells act on humoral immunity and induce vascular inflammatory response. 
Vascular endothelial growth factor (Vascular endothelial growth factor, VEGF) can cause 
excessive increased Vascular permeability, children with kawasaki disease can be detected 
in blood of Vascular endothelial growth factor, Vascular VEGF promote the white blood cells 
gathered in coronary inflammation of stimulation, the increased Vascular permeability, and 
stimulate the activation of peripheral blood mononuclear cell chemotaxis to endothelial 
injury and lead to local produce again producing VEGF, form a vicious circle, coronary blood 
vessels to participate in and lead to damage [7]. According to the study of Rao Xiao Hong et 
al., platelets are involved in vascular damage of Kawasaki disease. After thrombocytosis and 
enhanced activation, thrombocytosis causes thrombosis in the damaged coronary arteries, 
intima thickening, and release a variety of angioconstrictors and clotting substances, leading 
to myocardial function impairment, increased hypercoagulability and vascular blockage, 
resulting in ischemic necrosis of the myocardium.  
At present, there are many studies on gene fragments such as ITPKC, Casp3, TGF-S, BLK, 
CD40 and FCGR2a at home and abroad, suggesting that many genes are involved in the 
occurrence of Kawasaki disease and the development of CAL[8]. In conclusion, the 
mechanism of KD disease is a complex process, but studies have shown that it is the 
abnormal activation of immune cells and the large release of various cytokines, leading to 
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vascular endothelial damage and dysfunction, and the occurrence of cascading damage of 
coronary arteries. 
 
Pathological basis of coronary artery damage in Kawasaki disease  
The coronary arteritis model was induced by Lactobacillus casei cell wall extract (LCWE) [9]. 
Pathological sections of the coronary artery showed thickening of the vascular wall and 
invasion of inflammatory cells around the heart tissue, and plaques may appear. LCWE 
induced Kawasaki disease vasculitis is characterized by inflammatory cell infiltration in the 
aortic root, necrotic coronary artery arteritis, and then complete coronary artery stenosis 
due to lumen occlusion caused by LMP [10, 11]. In 2004, through pig model, it was found 
that the coronary arteries of pig heart were dilated differently. Pathologically, it was found 
that the inner elastic membrane was broken and the intimal hyperplasia changed, and the 
perivascular inflammatory infiltration was observed. Through the analysis and observation 
of the clinical data of children with Kawasaki disease, combined with a large number of 
animal models of Kawasaki disease theoretical research basis and clinical research to 
improve the understanding of Kawasaki disease induced coronary artery damage. It shows 
that Kawasaki disease is an inflammation of small and medium blood vessels, and long-term 
vascular inflammation eventually leads to coronary atherosclerosis. The coronary artery wall 
was thickened, the inner diameter of the main artery was widened, the intima was 
thickened, the valve and the intima of the atrium were slightly swollen, the neutrophils 
were scattered and infiltrated, the coronary artery lumen was expanded and the 
cardiomyocytes were necrotic and dissolved, and local fibers replaced the calcium salt 
deposition of tissue hyperplasia. The extravascular interstitium of the heart is edema, with a 
few lymphocyte infiltrates and diffuse hyperplasia of fibrous connective tissue. The 
muscular layer of blood vessels was destroyed, and the adventitia showed focal fibrinoid 
necrosis and fibrosis. White thrombosis is seen in the lumen. Severe and persistent coronary 
thrombosis with endothelial cell damage and myocardial cell necrosis results in irreversible 
heart changes. Through the study of animal model and pathological changes, the 
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Mechanism and effect of stem cell therapy 
Functionally, stem cells have unique biological characteristics, such as the ability to self-
renew, expand and limit the potential of differentiation, maintain and control cell 
regeneration, and then repair necrotic or damaged tissues. Through the theory of infection, 
as long as the inflammatory response caused by Kawasaki disease can be controlled or 
weakened, Kawasaki disease can be controlled or recovered. Therefore, a therapeutic 
measure is needed to inhibit or block the inflammatory response. In addition to promoting 
functional tissue regeneration and repair, stem cells also have a wide range of 
immunomodulatory and anti-fibrosis activities [12]. Macrophages in tissues are involved in 
the multiple roles of anti-inflammation and tissue repair in inflammatory injury. M1-type 
macrophages are dominant in the early stage of myocardial infarction, and M1-type 
macrophages lead to myocardial injury by phagocytosis, dissolution and digestion of 
necrotic myocardial tissue [13]. Type M2 macrophages participate in the anti-inflammatory 
response in the late stage of acute myocardial infarction and promote the effect of heart 
repair. Studies have shown that stem cell therapy can significantly increase the invasion of 
type M2 macrophages in the area of myocardial infarction, reduce fibrosis, increase 
angiogenesis, and improve cardiac function. A mouse model of myocardial infarction treated 
with stem cells showed that after one week of treatment, the number of M1 type in 
myocardial cells was less, the number of M2 type was increased, the number of residual 
myocardial cells was more, the infiltration of lymphocytes was reduced, the apoptotic index 
of myocardial cells and the deposition of myocardial collagen were decreased [14]. Peng Y 
[15-16] Studies have shown that stem cells reduce the expression of inflammatory factors 
and increase the expression of anti-inflammatory factors by adjusting the inflammatory 
response, so as to avoid excessive inflammatory response and tissue damage caused by 
inflammation. Mesenchymal stem cell-derived exosomes can enhance the M2 polarization 
effect of macrophages in myocardial tissue of myocardial infarction model, and inhibit the 
inflammation and apoptosis of myocardial tissue [17]. The transition from inflammatory 
injury tissue to pro-tissue repair in the inflammatory response is induced by the 
transformation of macrophages from M1 type to M2 type. The injection of mesenchymal 
stem cells induces the transformation of a large number of macrophages from M1 to M2, 
thereby reducing the inflammatory response of Kawasaki disease and promoting the repair 
of damaged heart tissue. 
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Stem cells have the ability to self-replicate, renew and effectively repair damaged tissues or 
organs [18]. Stem cells are a kind of relatively special cells, which are easy to obtain and do 
not involve many ethical issues [19-20] .Stem cells have homing properties and can be used 
as carrier tools to deliver biological agents in a directional manner, thus realizing the 
treatment of related diseases. The research of Zhao L et al. [21] demonstrated that stem cell 
DNA carries some gene points that determine the differentiation of muscle lines, thereby 
promoting the differentiation of stem cells into cardiomyocytes. Animal experiments have 
shown that the application of stem cells in the treatment of damaged myocardial cells can 
effectively improve the situation of myocardial blood supply and improve the body's cardiac 
function [22-23]. Human umbilical cord mesenchymal stem cells can differentiate into 
endothelium cardiomyocytes, and they have a wide range of sources with little immune 
response, so they have been used in the treatment of coronary artery damage caused by 
Kawasaki disease. After the injection of stem cells in animal models, the inner diameter of 
the main coronary artery was reduced, and a large amount of lymphocytes and eosinophils 
were infiltrated, but no obvious inflammatory response and injury changes were observed. 
Stem cells can successfully differentiate into vascular endothelial cells and some 
cardiomyocytes to repair heart tissue damaged by Kawasaki disease. 
 
SUMMARY AND PROSPECT 
Traditional treatments for Kawasaki disease are gamma globulin injections or oral aspirin. 
However, the 2004 American College of Cardiology guidelines state that the use of gamma 
globulin within five days of fever does not reduce the incidence of coronary damage, and 
there is a risk of developing resistance [24]; In addition, the price of gamma globulin is 
expensive, which increases the cost for the families of children. Stem cells play a key role in 
the regeneration and repair of coronary artery damage caused by Kawasaki disease, 
providing a new treatment method and idea to get rid of the limitations of traditional 
treatment, which is expected to successfully prevent the occurrence of CAL and improve the 
prognosis of patients with Kawasaki disease. However, it faces many problems. Stem cell 
therapy for coronary artery injury is still in the research stage, and the safety and 
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effectiveness of stem cell extraction need to be further studied and solved. However, with 
continuous efforts, stem cell therapy will become a more effective way to treat coronary 
artery damage. 
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